Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
World Journal of Clinical Oncology
|
July 29, 2024
Neoadjuvant treatment of rectal cancer: Where we are and where we are going
Elísabet González Del Portillo, Felipe Couñago, Fernando López-Campos
World Journal of Clinical Oncology
|
May 1, 2024
Management of lateral pelvic lymph nodes in rectal cancer: Is it time to reach an Agreement?
Sigfredo E Romero-Zoghbi, Fernando López-Campos, Felipe Couñago
World Journal of Clinical Oncology
|
February 25, 2025
Current and future perspectives in the management and treatment of colorectal cancer
Sigfredo E Romero-Zoghbi, Evita Krumina, Fernando López-Campos, et al.
Cancers
|
September 28, 2024
Impact of Dose-Escalated Chemoradiation on Pathological Complete Response in Patients with Locally Advanced Rectal Cancer
Carolina Domingo-Boluda, Diego Dualde, Teresa Taberner-Bonastre, et al.
World Journal of Clinical Oncology
|
March 8, 2021
Metastatic hormone-sensitive prostate cancer: How should it be treated?
Fernando López-Campos, Carmen González-San Segundo, Antonio José Conde-Moreno, et al.
Urologic Oncology
|
May 29, 2021
Is hypofractionation acceptable for prostate bed radiotherapy?
Fernando López Campos, Gemma Sancho Pardo, Xavier Maldonado Pijoan, et al.
Oncology
|
October 23, 2022
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer
Victor Duque-Santana, Fernando López-Campos, Margarita Martin-Martin, et al.
Journal of Personalized Medicine
|
November 27, 2021
Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity
Fernando López-Campos, Antonio Conde-Moreno, Marta Barrado Los Arcos, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 14, 2025
Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage
Cristina Ibáñez, Manuel Tourís-Lores, Álvaro Montesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 24, 2025
Efficacy and safety of rechallenge therapy with [177Lu]Lu-PSMA in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
Zineddine Belabaci, Leonie Schmidt, Mouhammed Sleiay, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
World Journal of Clinical Oncology
|
July 29, 2024
Neoadjuvant treatment of rectal cancer: Where we are and where we are going
Elísabet González Del Portillo, Felipe Couñago, Fernando López-Campos
World Journal of Clinical Oncology
|
May 1, 2024
Management of lateral pelvic lymph nodes in rectal cancer: Is it time to reach an Agreement?
Sigfredo E Romero-Zoghbi, Fernando López-Campos, Felipe Couñago
World Journal of Clinical Oncology
|
February 25, 2025
Current and future perspectives in the management and treatment of colorectal cancer
Sigfredo E Romero-Zoghbi, Evita Krumina, Fernando López-Campos, et al.
Cancers
|
September 28, 2024
Impact of Dose-Escalated Chemoradiation on Pathological Complete Response in Patients with Locally Advanced Rectal Cancer
Carolina Domingo-Boluda, Diego Dualde, Teresa Taberner-Bonastre, et al.
World Journal of Clinical Oncology
|
March 8, 2021
Metastatic hormone-sensitive prostate cancer: How should it be treated?
Fernando López-Campos, Carmen González-San Segundo, Antonio José Conde-Moreno, et al.
Urologic Oncology
|
May 29, 2021
Is hypofractionation acceptable for prostate bed radiotherapy?
Fernando López Campos, Gemma Sancho Pardo, Xavier Maldonado Pijoan, et al.
Oncology
|
October 23, 2022
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer
Victor Duque-Santana, Fernando López-Campos, Margarita Martin-Martin, et al.
Journal of Personalized Medicine
|
November 27, 2021
Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity
Fernando López-Campos, Antonio Conde-Moreno, Marta Barrado Los Arcos, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 14, 2025
Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage
Cristina Ibáñez, Manuel Tourís-Lores, Álvaro Montesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 24, 2025
Efficacy and safety of rechallenge therapy with [177Lu]Lu-PSMA in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
Zineddine Belabaci, Leonie Schmidt, Mouhammed Sleiay, et al.
Page
of 7